Total Funding
92
20
Total FundingSeries A raised
Growth Score 92 in past quarter
2 pts
Heat Score 20 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24721
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Tim Dyer: Founder, Chief Executive Officer, and Chief Financial OfficerPast Role: Addex Therapeutics, Co-Founder, Chief Financial Officer, and Business Development
About the Company
Neurosterix aims to create novel medicines based on allosteric modulation that overcome the limitations of traditional treatments and have the potential to significantly enhance patients' lives.